Jellinger KA - Search Results

1

Chromogranin peptides in Alzheimer's disease.

Lechner T, Adlassnig C, Humpel C, Kaufmann WA, Maier H, Reinstadler-Kramer K, Hinterhölzl J, Mahata SK, Jellinger KA, Marksteiner J. Lechner T, et al. Among authors: jellinger ka. Exp Gerontol. 2004 Jan;39(1):101-13. doi: 10.1016/j.exger.2003.09.018. Exp Gerontol. 2004. PMID: 14724070

2

A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease.

Weiler R, Lassmann H, Fischer P, Jellinger K, Winkler H. Weiler R, et al. FEBS Lett. 1990 Apr 24;263(2):337-9. doi: 10.1016/0014-5793(90)81408-g. FEBS Lett. 1990. PMID: 2110534 Free article.

3

Synaptic pathology of Alzheimer's disease.

Lassmann H, Fischer P, Jellinger K. Lassmann H, et al. Ann N Y Acad Sci. 1993 Sep 24;695:59-64. doi: 10.1111/j.1749-6632.1993.tb23028.x. Ann N Y Acad Sci. 1993. PMID: 8239314 Review.

4

Creutzfeldt-Jakob disease in Austria.

Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, Maier H, Budka H. Hainfellner JA, et al. J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):139-42. doi: 10.1136/jnnp.61.2.139. J Neurol Neurosurg Psychiatry. 1996. PMID: 8708680 Free PMC article. Clinical Trial.

5

Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis.

Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H. Stadelmann C, et al. J Neuropathol Exp Neurol. 1998 May;57(5):456-64. doi: 10.1097/00005072-199805000-00009. J Neuropathol Exp Neurol. 1998. PMID: 9596416

6

Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease.

Marksteiner J, Lechner T, Kaufmann WA, Gurka P, Humpel C, Nowakowski C, Maier H, Jellinger KA. Marksteiner J, et al. Among authors: jellinger ka. Acta Neuropathol. 2000 Aug;100(2):205-12. doi: 10.1007/s004010000239. Acta Neuropathol. 2000. PMID: 10963369

7

Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical study.

Embacher N, Kaufmann WA, Beer R, Maier H, Jellinger KA, Poewe W, Ransmayr G. Embacher N, et al. Among authors: jellinger ka. Acta Neuropathol. 2001 Nov;102(5):426-34. doi: 10.1007/s004010100438. Acta Neuropathol. 2001. PMID: 11699554

8

Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia.

Nowakowski C, Kaufmann WA, Adlassnig C, Maier H, Salimi K, Jellinger KA, Marksteiner J. Nowakowski C, et al. Among authors: jellinger ka. Schizophr Res. 2002 Nov 1;58(1):43-53. doi: 10.1016/s0920-9964(01)00389-9. Schizophr Res. 2002. PMID: 12363389

9

Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons.

Attems J, Quass M, Gartner W, Nabokikh A, Wagner L, Steurer S, Arbes S, Lintner F, Jellinger K. Attems J, et al. Exp Gerontol. 2007 Mar;42(3):215-22. doi: 10.1016/j.exger.2006.09.018. Epub 2006 Nov 20. Exp Gerontol. 2007. PMID: 17116382

10

Multiple sclerosis and Alzheimer's disease.

Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H. Dal Bianco A, et al. Ann Neurol. 2008 Feb;63(2):174-83. doi: 10.1002/ana.21240. Ann Neurol. 2008. PMID: 17924575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

805 results

Search Page